In blood samples from patients with preinvasive and microinvasive cervical cancer tested our study, we could observe significantly higher proportion of CD4+CD95+ Т lymphocytes with a concomitant tendency for decreased percentage of CD8+CD95+ Т lymphocytes compared to healthy controls. The gene discussed is FAS; the disease is cervical carcinoma.